Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction.

BACKGROUND The utility of contrast MRI for assessing myocardial viability in stable coronary artery disease (CAD) with left ventricular dysfunction is uncertain. We therefore performed cine and contrast MRI in 24 stable patients with CAD and regional contractile abnormalities and compared MRI findings with rest-redistribution 201Tl imaging and dobutamine echocardiography. METHODS AND RESULTS Delayed MRI contrast enhancement patterns were examined from 3 to 15 minutes after injection of 0.1 mmol/kg IV gadolinium diethylenetriamine pentaacetic acid (Gd-DTPA). Comparable MRI and 201Tl basal and midventricular short-axis images were subdivided into 6 segments. Segments judged nonviable by quantitative and qualitative assessment of 201Tl scans showed persistent, systematically greater MRI contrast signal intensity than segments judged viable (P</=0.002). Delayed contrast hyperenhancement also occurred in segments judged nonviable by dobutamine echocardiography (P</=0.03). The presence or absence of hyperenhancement correlated most closely with nonviability and viability, respectively, in segments that were akinetic or dyskinetic under resting conditions (83% concordance with 201Tl in both cases). In segments with resting hypokinesis, 58% of segments showing hyperenhancement were judged viable by 201Tl and may have represented an admixture of scar tissue and viable myocardium. CONCLUSIONS Delayed (by 3 to 15 minutes) hyperenhancement of Gd-DTPA contrast-enhanced MRI images occurs frequently in dysfunctional areas of the left ventricle in patients with stable CAD. Hyperenhancement is associated with nonviability by rest-redistribution 201Tl scintigraphy and dobutamine echocardiography, particularly in regions exhibiting resting akinesis/dyskinesis. The absence of hyperenhancement correlates with radionuclide and echocardiographic determinations of viability, regardless of resting contractile function.

[1]  U Sechtem,et al.  Chronic myocardial infarction: assessment of morphology, function, and perfusion by gradient echo magnetic resonance imaging and 99mTc-methoxyisobutyl-isonitrile SPECT. , 1992, American heart journal.

[2]  J. Griffith,et al.  Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201Tl and 99mTc-sestamibi. , 1994, Circulation.

[3]  S. Kaul,et al.  Quantitative Planar Rest‐Redistribution 201 Imaging in Detection of Myocardial Viability and Prediction of Improvement in Left Ventricular Function After Coronary Bypass Surgery in Patients With Severely Depressed Left Ventricular Function , 1993, Circulation.

[4]  R. Peshock,et al.  Magnetic resonance imaging of acute myocardial infarction: gadolinium diethylenetriamine pentaacetic acid as a marker of reperfusion. , 1986, Circulation.

[5]  J. Seward,et al.  Stress echocardiography. Part II. Dobutamine stress echocardiography: techniques, implementation, clinical applications, and correlations. , 1995, Mayo Clinic proceedings.

[6]  M E Moseley,et al.  Assessment of myocardial salvage after ischemia and reperfusion using magnetic resonance imaging and spectroscopy. , 1989, Circulation.

[7]  J A Frank,et al.  Regional Left Ventricular Wall Thickening: Relation to Regional Uptake of 18Fluorodeoxyglucose and 201TI in Patients With Chronic Coronary Artery Disease and Left Ventricular Dysfunction , 1992, Circulation.

[8]  E. McVeigh,et al.  A magnetization‐driven gradient echo pulse sequence for the study of myocardial perfusion , 1995, Magnetic resonance in medicine.

[9]  R. Peshock,et al.  Gadolinium-DTPA-enhanced nuclear magnetic resonance imaging of reperfused myocardium: identification of the myocardial bed at risk. , 1988, Journal of the American College of Cardiology.

[10]  A de Roos,et al.  Usefulness of ultrafast magnetic resonance imaging in healed myocardial infarction. , 1992, The American journal of cardiology.

[11]  P. V. van Dijkman,et al.  Acute, subacute, and chronic myocardial infarction: quantitative analysis of gadolinium-enhanced MR images. , 1991, Radiology.

[12]  F. C. Dougherty,et al.  Magnetic resonance imaging (MRI) in different stages of myocardial infarction using the contrast agent gadolinium‐DTPA , 1986, Clinical cardiology.

[13]  R. Kim,et al.  Myocardial Gd-DTPA kinetics determine MRI contrast enhancement and reflect the extent and severity of myocardial injury after acute reperfused infarction. , 1996, Circulation.

[14]  R. Slutsky,et al.  Tissue distribution and magnetic resonance spin lattice relaxation effects of gadolinium-DTPA. , 1985, Radiology.

[15]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[16]  A. Soricelli,et al.  Assessment of myocardial viability in patients with chronic coronary artery disease. Rest-4-hour-24-hour 201Tl tomography versus dobutamine echocardiography. , 1996, Circulation.

[17]  F. Fedele,et al.  Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction: role of magnetic resonance imaging. , 1994, American heart journal.

[18]  A. Bol,et al.  Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. , 1995, The American journal of physiology.

[19]  C. Higgins,et al.  Occlusive and reperfused myocardial infarcts: differentiation with Mn-DPDP--enhanced MR imaging. , 1989, Radiology.

[20]  Hubert W. Vliegen,et al.  Magnetic Resonance Imaging in Coronary Artery Disease , 1991, Developments in Cardiovascular Medicine.

[21]  M. Verani,et al.  Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function. , 1997, Circulation.

[22]  S B Reeder,et al.  Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. , 1997, Circulation.

[23]  F. Prato,et al.  The determination of myocardial viability using Gd‐DTPA in a canine model of acute myocardial ischemia and reperfusion , 1996, Magnetic resonance in medicine.

[24]  D Tscholakoff,et al.  Occlusive and reperfused myocardial infarcts: effect of Gd-DTPA on ECG-gated MR imaging. , 1986, Radiology.

[25]  E. Atalar,et al.  Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. , 1995, Circulation.

[26]  R. Brasch,et al.  Contrast-enhanced NMR imaging: animal studies using gadolinium-DTPA complex. , 1984, AJR. American journal of roentgenology.

[27]  M. Verani,et al.  Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function. , 1997, Circulation.

[28]  R. Judd,et al.  Physiological basis of myocardial contrast enhancement in fast magnetic resonance images of 2-day-old reperfused canine infarcts. , 1995, Circulation.